|Bid||0.0000 x 900|
|Ask||0.0000 x 800|
|Day's range||0.6932 - 0.7200|
|52-week range||0.3650 - 1.6900|
|Beta (5Y monthly)||0.58|
|PE ratio (TTM)||2.12|
|Earnings date||07 Nov 2022 - 11 Nov 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||0.80|
Epizyme (EPZM) posts a narrower-than-expected loss in the second quarter. Revenues beat estimates.
Reata (RETA) reports a wider-than-expected loss in the second quarter of 2022, while revenues miss estimates. Stock falls after updates on pipeline programs.
Puma Biotech (PBYI) beats earnings and revenue estimates in second-quarter 2022. PBYI's stock surges at market close following the news.